At present, it is more widely recognized that TGFBR2 expression decreases in most NSCLC patients, and increasing TGFBR2 expression suppresses the proliferation and invasion of NSCLC (40, 41). Here, TGFBR2 is linked to non-small cell lung carcinoma.